Clinical Trials Directory

Trials / Completed

CompletedNCT04043793

ICU-acquired Colonization and Infection Related to MDR in Immunocompromised Patients

Intensive Care Unit (ICU)-Acquired Colonization and Infection Related to Multidrug Resistant Bacteria (MDR) in Immunocompromised Patients

Status
Completed
Phase
Study type
Observational
Enrollment
759 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

the number of immunocompromised patients hospitalized in the intensive care units (ICU) is increasing. They are at higher risk of colonization and/or infection with multi-resistant bacteria (MDR). However this risk is not well characterized. ICU acquired infections related to MDR are associated with increased morbidity and mortality. The aim of this study is to compare the incidence of ICU-acquired colonization and ICU-acquired infection related to MDR between immunocompromized and immunocompetent patients. The risk factors for ICU-acquired colonization and ICU-acquired infections, and their impact on outcome will also be evaluated and compared between immunocompromised and immunocompetent patients.

Conditions

Timeline

Start date
2019-11-07
Primary completion
2021-12-07
Completion
2021-12-07
First posted
2019-08-02
Last updated
2022-10-05

Locations

7 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04043793. Inclusion in this directory is not an endorsement.

ICU-acquired Colonization and Infection Related to MDR in Immunocompromised Patients (NCT04043793) · Clinical Trials Directory